HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Impact of PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does the PEPPI software make it easier for patients to access PEP/PrEP? Researchers will compare pharmacists' implementation and patients' access when using the PEPPI software and when not using the PEPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide PEP/PrEP services as normal while using the PEPPI software. Patients will be asked to receive PEP/PrEP services from a pharmacist as normal, while using the PEPPI software.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• 18 years of age or older

• Provide, or willing to provide, PEP/PrEP services in a participating pharmacy

• Use the PEPPI software to provide birth control services

• 18 years of age or older

• Seek PEP or PrEP services at a participating pharmacy

• Use the PEPPI software to receive PEP/PrEP services at a participating pharmacy

Locations
United States
California
EmpoweRx, Inc
RECRUITING
Del Mar
Contact Information
Primary
Jenny L Newlon, PharmD, PhD
jenny@birthcontrolpharmacist.com
8584120984
Backup
Sally Rafie, PharmD
Sally@birthcontrolpharmacist.com
Time Frame
Start Date: 2026-08
Estimated Completion Date: 2028-09
Participants
Target number of participants: 195
Treatments
Other: PEPPI Pharmacies
This is a single-arm trial, so all pharmacies will serve as their own control. We will enroll 10 community pharmacies. These 10 pharmacies will continue to provide PEP/PrEP services as normal for several months (control). Then, we will introduce the first phase of the intervention: the minimally viable product (MVP) version of the PEPPI software. The second phase of the intervention will be the enhanced version of the PEPPI software. The pharmacies will continue to provide PEP/PrEP services while using the PEPPI software in place of any paper or electronic processes that they were previously using. The results will then be compared between the control and the intervention periods.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Mental Health (NIMH)
Leads: EMPOWERX INC

This content was sourced from clinicaltrials.gov